BLOOD PLASMA PRODUCTS

Brand Owner (click to sort) Address Description
BLUEVANCE BlueVance Biotechnology Corporation 3005 South Leisure World Boulevard Suite 810 Silver Spring MD 20906 Blood plasma products, namely, blood plasma;
CELLIANCE MERCK KGAA Frankfurter Str. 250 64293 Darmstadt F128/002 Germany Blood plasma products, namely, blood-typing reagents and diagnostic test kit control materials consisting primarily of plasma, monoclonal antibodies and/or immune globulins, all for medical use;Reagents for medical or scientific research use; kits for the expression, amplification, purification and analysis of biological samples, said kits consisting primarily of one or more of the following; proteins, nucleic acids, cells, gels, probes, buffers, stains and associated reagents and devices for carrying out said purposes; biochemical reagents for research purposes, namely cell culture media components, supplements, and additives; biochemicals for scientific and research use, namely, monoclonal antibodies, polyclonal antibodies, purified recombinant proteins, purified natural proteins fetal bovine serum, cell growth supplements, namely, biochemicals for affinity purification, biochemicals for western immuno blotting, biochemicals for immunocyto chemistry;
SEROLOGICALS SEROLOGICALS ROYALTY COMPANY Second Floor, Suite No. 1 Office No. 15 First Commercial Freeport, Grand Bahama Bahamas blood plasma products; namely, blood-typing reagents and diagnostic test kit control materials;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to a method for using lectins that bind to pathogens having high mannose surface glycoproteins or fragments thereof which contain high mannose glycoproteins, to remove them from infected blood or plasma in an extracorporeal setting. Accordingly, the present invention provides a method for reducing viral load in an individual comprising the steps of obtaining blood or plasma from the individual, passing the blood or plasma through a porous hollow fiber membrane wherein lectin molecules are immobilized within the porous exterior portion of the membrane, collecting pass-through blood or plasma and reinfusing the pass-through blood or plasma into the individual.